Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

20,440.0000 JPY 30.0000 0.15%

As of 01:55:30 ET on 05/28/2015.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 20,500.0000 High - Low: 20,510.0000 - 20,420.0000 Primary Exchange: Tokyo
Volume: 69 52-Week Range: 14,420.0000 - 22,000.0000 Beta vs TP17PHRM: 0.9469

ETF Chart for 1621

No chart data available.
  • 1621:JP 20,440.0000
  • 1D
  • 1M
  • 1Y
20,410.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2015-05-28) 20,390.4000
Assets (M) (on 2015-05-28) 1,254.0000
Shares out (M) 0.06
Market Cap (M) 1,256.77
% Premium 0.24
Average 52-Week % Premium 0.0679
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 5.22%

Performance for 1621

1-Month -1.40% 1-Year +46.46%
3-Month +7.53% 3-Year +33.58%
Year To Date +24.07% 5-Year +19.86%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 04/30/2015
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 28,800 177,321,600 21.232%
Astellas Pharma Inc 87,600 163,768,200 19.610%
Eisai Co Ltd 10,100 81,123,200 9.714%
Otsuka Holdings Co Ltd 15,300 58,040,550 6.950%
Daiichi Sankyo Co Ltd 25,900 54,014,450 6.468%
Shionogi & Co Ltd 12,000 47,340,000 5.668%
Ono Pharmaceutical Co Ltd 3,500 45,395,000 5.436%
Chugai Pharmaceutical Co Ltd 7,700 28,143,500 3.370%
Santen Pharmaceutical Co Ltd 14,100 22,292,100 2.669%
Mitsubishi Tanabe Pharma Corp 9,000 18,315,000 2.193%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil